Giant%20Cell%20Tumor%20of%20Bone
Showing 1 - 25 of >10,000
Giant Cell Tumor of Bone Trial in Beijing (Narlumosbart, Denosumab)
Not yet recruiting
- Giant Cell Tumor of Bone
-
Beijing, Beijing, ChinaBeijing Ji Shui Tan Hospital
Apr 16, 2023
Giant Cell Tumor of Bone Trial in Hangzhou, Lishui, Ningbo (4mg ZOL loaded gentamicin PMMA, gentamicin PMMA)
Not yet recruiting
- Giant Cell Tumor of Bone
- 4mg ZOL loaded gentamicin PMMA
- gentamicin PMMA
-
Hangzhou, Zhejiang, China
- +2 more
Feb 1, 2023
Giant Cell Tumor of Bone Trial (Dietary Supplement: Calcium/Vitamin D)
Active, not recruiting
- Giant Cell Tumor of Bone
- Dietary Supplement: Calcium/Vitamin D
-
Beijing, ChinaBeijing Ji Shui Tan Hospital
Oct 13, 2022
Giant Cell Tumor of Bone Trial in Canada, United States (Zoledronic Acid)
Recruiting
- Giant Cell Tumor of Bone
- Zoledronic Acid
-
Los Angeles, California
- +15 more
Oct 19, 2022
Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)
Recruiting
- Bone Sarcoma
- +15 more
- Aldesleukin
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2022
Giant Cell Tumor of Bone Trial in Worldwide (Denosumab (Cohort A))
Active, not recruiting
- Giant Cell Tumor of Bone
- Denosumab (Cohort A)
-
Santa Monica, California
- +13 more
Dec 21, 2021
Giant Cell Tumor of the Bone in Young Patients
Completed
- Giant Cell Tumor of Bone
-
Bologna, ItalyIstituto Ortopedico Rizzoli
May 3, 2021
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath Trial (Pimicotinib(ABSK021),
Not yet recruiting
- Tenosynovial Giant Cell Tumor
- +2 more
- Pimicotinib(ABSK021)
- Placebo
- (no location specified)
Apr 5, 2023
Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)
Not yet recruiting
- Cancer Risk
- +30 more
- Samples
-
Boston, MassachusettsDana Farber Cancer Institute
Jul 14, 2022
TGCT Trial in Washington, Baltimore (Emactuzumab, Placebo)
Active, not recruiting
- TGCT
- Emactuzumab
- Placebo
-
Washington, District of Columbia
- +1 more
Sep 23, 2022
Pigmented Villonodular Synovitis, Diffuse-type Giant Cell Tumor, Tenosynovial Giant Cell Tumor Trial in United States
Active, not recruiting
- Pigmented Villonodular Synovitis
- +2 more
-
Santa Monica, California
- +6 more
Jan 31, 2022
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, TGCT Trial in Germany, Poland, Ukraine (AMB-05X)
Active, not recruiting
- Tenosynovial Giant Cell Tumor
- +3 more
- AMB-05X
-
Berlin, Germany
- +4 more
Oct 5, 2022
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath Trial in Worldwide
Recruiting
- Tenosynovial Giant Cell Tumor
- +4 more
- vimseltinib
- Placebo
-
Duarte, California
- +34 more
Jan 17, 2023
Bone Giant Cell Tumor Trial in Worldwide (Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA])
Terminated
- Bone Giant Cell Tumor
- Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]
-
Bologna, Italy
- +7 more
Jan 4, 2021
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis Trial in Worldwide (AMB-05X)
Active, not recruiting
- Tenosynovial Giant Cell Tumor
- Pigmented Villonodular Synovitis
- AMB-05X
-
Columbus, Ohio
- +5 more
Oct 5, 2022
Tenosynovial Giant Cell Tumor Trial in Worldwide (Pexidartinib)
Active, not recruiting
- Tenosynovial Giant Cell Tumor
-
Scottsdale, Arizona
- +15 more
Apr 29, 2022
Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- Laboratory Biomarker Analysis
- Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Jan 4, 2023
Prognostic Prediction Based on Radiomics of Giant Cell Tumor of
Completed
- Spinal Tumor
- RANK/RANKL(RANK: Receptor Activator of Nuclear factor Kappa-Β /RANKL:Receptor Activator of Nuclear factor Kappa-Β Ligand)
-
Beijing, Please Select An Option Below, ChinaPeking University third hospital
Jun 28, 2021
Blood, Urine, and Bone Marrow
Recruiting
- Non Small Cell Lung Cancer
- +5 more
- Test for circulating tumor cells, DNA alterations
-
Columbia, MissouriHarry S Truman Veterans Memorial Hospital
Oct 31, 2022
Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)
Not yet recruiting
- Soft Tissue Sarcoma
- Bone Sarcoma
- Cyclophosphamide
- attIL2-T cells
-
Houston, TexasM D Anderson Cancer Center
Nov 10, 2022